Synbiotic Supplementation Attenuates Doxorubicin-Induced Oxidative Stress and Inflammation in the Gut-Heart Axis of Chemotherapy-Treated Mice
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26115136 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Chi-Feng Cheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Ren Ai Branch, Taipei City Hospital, Taipei 10629, Taiwan. Hauptthemen laut MEDLINE: Doxorubicin, Synbiotics, Gastrointestinal Microbiome, Oxidative Stress. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was partly funded by Industry-Academic Cooperation Project from ARJIL Pharmaceu-ticals LLC, TTY Biopharm Co., Ltd., and Shiun Chao Biopharm Co., Ltd., the Industry-Academic Cooperation Project from ARJIL Pharmaceuticals LLC.
Themen: Onkologische Pflege
Abstract (Originalsprache)
The gut microbiome supports immune health and influences gut and heart functions through the gut-heart axis. Synbiotics (SBT), combining probiotics and prebiotics, help restore microbiome balance. Chemotherapy often disrupts this balance, leading to adverse effects on the gut and heart. This study explores the potential of SBT supplementation in reducing heart and gut inflammation caused by doxorubicin (DOX) chemotherapy. The gut microbiome plays a vital role in immune health, and metabolites produced by gut bacteria contribute to physiological functions through the gut-heart axis. Chemotherapy drugs often disrupt these processes, leading to adverse effects on internal organs. Using 24 ICR male mice divided into four groups, the experiment assessed the impact of SBT on DOX-induced damage. Results indicated that DOX treatment significantly worsened survival rates, physical performance, heart function, and gut microbiome stability. However, co-treatment with SBT improved these markers, suggesting that SBT may help mitigate chemotherapy-induced side effects in cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Ren Ai Branch, Taipei City Hospital, Taipei 10629, Taiwan.
- School of Life Science, National Taiwan Normal University, Taipei 11677, Taiwan.
- ARJIL Pharmaceuticals LLC, Hsinchu City 30013, Taiwan.
ORCID-Profile: Chung-Hsin Wu
Förderung
- This study was partly funded by Industry-Academic Cooperation Project from ARJIL Pharmaceu-ticals LLC, TTY Biopharm Co., Ltd., and Shiun Chao Biopharm Co., Ltd.
- the Industry-Academic Cooperation Project from ARJIL Pharmaceuticals LLC
Zitieren
APA
Cheng, C. F., Nguyen, T. K. N., Shen, S. C., Chen, B. Y., Wu, Y. B., Liang, H. J., & Wu, C. H. (2025). Synbiotic Supplementation Attenuates Doxorubicin-Induced Oxidative Stress and Inflammation in the Gut-Heart Axis of Chemotherapy-Treated Mice. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26115136
Vancouver
Cheng CF, Nguyen TKN, Shen SC, Chen BY, Wu YB, Liang HJ, et al. Synbiotic Supplementation Attenuates Doxorubicin-Induced Oxidative Stress and Inflammation in the Gut-Heart Axis of Chemotherapy-Treated Mice. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26115136
BibTeX
@article{Cheng2025,
author = {Cheng, Chi-Feng and Nguyen, Thi Kim Ngan and Shen, Szu-Chuan and Chen, Bo-Yu and Wu, Yeh-B and Liang, Hui-Ju and Wu, Chung-Hsin},
title = {Synbiotic Supplementation Attenuates Doxorubicin-Induced Oxidative Stress and Inflammation in the Gut-Heart Axis of Chemotherapy-Treated Mice},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26115136}
}
EUVIMED